ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

President Obama Signs FDA User Fee Act Into Law

July 13, 2012

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

In Brief: Potter New AACI President, Sartorlli President Elect; NCI Staffers Get NIH Director’s Award

July 18, 1986

NCI Asks Centers To Limit Increases In Applying For Support Grant Renewals.

October 12, 2001

AACR, ASCO Publish Reports Examining U.S. Cancer Care

April 4, 2014

Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths

June 24, 1994